Answer
Myoview (tetrofosmin) requires careful benefit–risk consideration in patients with renal or hepatic impairment because increased radiation exposure is possible.
Sources for this answer
- MYOVIEW 230 micrograms kit for radiopharmaceutical preparationGE Healthcare Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked